Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing
Abstract Broadly neutralizing antibodies (bNAbs) targeting the HIV-1 envelope glycoprotein (Env) have the capacity to delay viral rebound when administered to people with HIV-1 (PWH) during anti-retroviral therapy (ART) interruption. To further enhance the performance of bNAbs through their Fc effec...
| Main Authors: | , , , , , , , , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
Nature Portfolio
2024-08-01
|
| 叢編: | Communications Biology |
| 在線閱讀: | https://doi.org/10.1038/s42003-024-06659-8 |